|
1
|
Shin HR, Carlos MC and Varghese C: Cancer
control in the Asia Pacific region: Current status and concerns.
Jpn J Clin Oncol. 42:867–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Song YX and Wang ZN: Non-coding
RNAs in gastric cancer. Gene. 560:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murayama Y, Oritani K and Tsutsui S: Novel
CD9-targeted therapies in gastric cancer. World J Gastroenterol.
21:3206–3213. 2015.PubMed/NCBI
|
|
4
|
Smalley SR, Benedetti JK, Haller DG,
Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson
JA, Jessup JM, et al: Updated analysis of SWOG-directed intergroup
study 0116: A phase III trial of adjuvant radiochemotherapy versus
observation after curative gastric cancer resection. J Clin Oncol.
30:2327–2333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du YB, Dong B, Shen LY, Yan WP, Dai L,
Xiong HC, Liang Z, Kang XZ, Qin B and Chen KN: The survival
predictive significance of HOXC6 and HOXC8 in esophageal squamous
cell carcinoma. J Surg Res. 188:442–450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grier DG, Thompson A, Kwasniewska A,
McGonigle GJ, Halliday HL and Lappin TR: The pathophysiology of HOX
genes and their role in cancer. J Pathol. 205:154–171. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chariot A and Castronovo V: Detection of
HOXA1 expression in human breast cancer. Biochem Biophys Res
Commun. 222:292–297. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Devita G, Barba P, Odartchenko N, Givel
JC, Freschi G, Bucciarelli G, Magli MC, Boncinelli E and Cillo C:
Expression of homeobox-containing genes in primary and metastatic
colorectal-cancer. Eur J Cancer. 29A:887–893. 1993. View Article : Google Scholar
|
|
9
|
Fujiki K, Duerr EM, Kikuchi H, Ng A,
Xavier RJ, Mizukami Y, Imamura T, Kulke MH and Chung DC: Hoxc6 is
overexpressed in gastrointestinal carcinoids and interacts with
JunD to regulate tumor growth. Gastroenterology. 135:907–916. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li B, Jin H, Yu Y, Gu C, Zhou X, Zhao N
and Feng Y: HOXA10 is overexpressed in human ovarian clear cell
adenocarcinoma and correlates with poor survival. Int J Gynecol
Cancer. 19:1347–1352. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen KN, Gu ZD, Ke Y, Li AY, Shi XT and Xu
GW: Expression of 11 HOX genes is deregulated in esophageal
squamous cell carcinoma. Clin Cancer Res. 11:1044–1049.
2005.PubMed/NCBI
|
|
12
|
Zhang Q, Jin XS, Yang ZY, Wei M, Liu BY
and Gu QL: Upregulated Hoxc6 expression is associated with poor
survival in gastric cancer patients. Neoplasma. 60:439–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yahagi N, Kosaki R, Ito T, Shimada H,
Tomita M, Takahashi T and Kosaki K: Position-specific expression of
HOX genes along adult gastrointestinal tract in humans. Congenit
Anom (Kyoto). 44:18–26. 2004. View Article : Google Scholar
|
|
14
|
Chen SJ, Lin JP and Si JM: Experimental
study on HOXC6 interference suppression malignant biological
behavior in gastric cancer. Proceedings of the 7th Zhejiang
Digestive Disease Academic Congress and the American
Gastroenterological Association the First China Academic Forum;
China Academic Journal Electronic Publishing House; China: pp.
88–89. 2014
|
|
15
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YP, Huang LY, Sun WM, Zhang ZZ, Fang
JZ, Wei BF, Wu BH and Han ZG: Insulin receptor tyrosine kinase
substrate activates EGFR/ERK signalling pathway and promotes cell
proliferation of hepatocellular carcinoma. Cancer Lett. 337:96–106.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abbott KL, Nyre ET, Abrahante J, Ho YY,
Isaksson Vogel R and Starr TK: The candidate cancer gene database:
A database of cancer driver genes from forward genetic screens in
mice. Nucleic Acids Res. 43(Database Issue): D844–D848. 2015.
View Article : Google Scholar :
|
|
18
|
Nadauld LD, Garcia S, Natsoulis G, Bell
JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, et al:
Metastatic tumor evolution and organoid modeling implicate TGFBR2
as a cancer driver in diffuse gastric cancer. Genome Biol.
15:4282014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barthélémy P, Aftimos P and Awada A: New
generations of targeted therapies fighting the resistance in solid
tumors. Curr Opin Oncol. 27:243–249. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rolfo C, Bronte G, Sortino G,
Papadimitriou K, Passiglia F, Fiorentino E, Marogy G, Russo A and
Peeters M: The role of targeted therapy for gastrointestinal
tumors. Expert Rev Gastroenterol Hepatol. 8:875–885. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cargnello M, Tcherkezian J and Roux PP:
The expanding role of mTOR in cancer cell growth and proliferation.
Mutagenesis. 30:169–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang H, Zhai YY, Hu TT and Han ZG:
Expression of PAGE5 and effect on proliferation and migration in
hepatocellular carcinoma. Journal of Lanzhou University (Medical
Sciences). 41:23–28. 2015.In Chinese.
|
|
23
|
Condamine T, Ramachandran I, Youn JI and
Gabrilovich DI: Regulation of tumor metastasis by myeloid-derived
suppressor cells. Annu Rev Med. 66:97–110. 2015. View Article : Google Scholar :
|
|
24
|
Sayegh ET, Burch EA, Henderson GA, Oh T,
Bloch O and Parsa AT: Tumor-to-tumor metastasis: Breast carcinoma
to meningioma. J Clin Neurosci. 22:268–274. 2015. View Article : Google Scholar
|
|
25
|
Wurm M, Kowalski J, Heckl D, Zhang XB,
Nelson V, Beard BC and Kiem HP: Ectopic expression of HOXC6 blocks
myeloid differentiation and predisposes to malignant
transformation. Exp Hematol. 42:114–125.e4. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moon SM, Kim SA, Yoon JH and Ahn SG: HOXC6
Is deregulated in human head and neck squamous cell carcinoma and
modulates Bcl-2 expression. J Biol Chem. 287:35678–35688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Win KT and Li CF: HOXC6 overexpression as
a poor prognostic factor in patients with nasopharyngeal carcinoma.
Modern Pathology. 27:331A2014.In Chinese.
|
|
28
|
Subramaniam A, Shanmugam MK, Perumal E, Li
F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, et al:
Potential role of signal transducer and activator of transcription
(STAT)3 signaling pathway in inflammation, survival, proliferation
and invasion of hepatocellular carcinoma. Biochim Biophys Acta.
1835:46–60. 2013.
|
|
29
|
Wells A, Grahovac J, Wheeler S, Ma B and
Lauffenburger D: Targeting tumor cell motility as a strategy
against invasion and metastasis. Trends Pharmacol Sci. 34:283–289.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim HC, Kim YS, Oh HW, Kim K, Oh SS, Kim
JT, Kim BY, Lee SJ, Choe YK, Kim DH, et al: Collagen triple helix
repeat containing 1 (CTHRC1) acts via ERK-dependent induction of
MMP9 to promote invasion of colorectal cancer cells. Oncotarget.
5:519–529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Merdad A, Karim S, Schulten HJ, Dallol A,
Buhmeida A, Al-Thubaity F, Gari MA, Chaudhary AG, Abuzenadah AM and
Al-Qahtani MH: Expression of matrix metalloproteinases (MMPs) in
primary human breast cancer: MMP-9 as a potential biomarker for
cancer invasion and metastasis. Anticancer Res. 34:1355–1366.
2014.PubMed/NCBI
|
|
32
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
SOX2 promotes the migration and invasion of laryngeal cancer cells
by induction of MMP-2 via the PI3K/Akt/mTOR pathway. Oncol Rep.
31:2651–2659. 2014.PubMed/NCBI
|
|
33
|
Zhang W, Liu Y and Wang CW: S100A4
promotes squamous cell laryngeal cancer Hep-2 cell invasion via
NF-kB/MMP-9 signal. Eur Rev Med Pharmacol Sci. 18:1361–1367.
2014.PubMed/NCBI
|
